Functional Living Trileaflet Heart Valves Grown In Vitro

Background—Previous tissue engineering approaches to create heart valves have been limited by the structural immaturity and mechanical properties of the valve constructs. This study used an in vitro pulse duplicator system to provide a biomimetic environment during tissue formation to yield more mature implantable heart valves derived from autologous tissue. Methods and Results—Trileaflet heart valves were fabricated from novel bioabsorbable polymers and sequentially seeded with autologous ovine myofibroblasts and endothelial cells. The constructs were grown for 14 days in a pulse duplicator in vitro system under gradually increasing flow and pressure conditions. By use of cardiopulmonary bypass the native pulmonary leaflets were resected, and the valve constructs were implanted into 6 lambs (weight 19±2.8 kg). All animals had uneventful postoperative courses, and the valves were explanted at 1 day and at 4, 6, 8, 16, and 20 weeks. Echocardiography demonstrated mobile functioning leaflets without stenosis, thrombus, or aneurysm up to 20 weeks. Histology (16 and 20 weeks) showed uniform layered cuspal tissue with endothelium. Environmental scanning electron microscopy revealed a confluent smooth valvular surface. Mechanical properties were comparable to those of native tissue at 20 weeks. Complete degradation of the polymers occurred by 8 weeks. Extracellular matrix content (collagen, glycosaminoglycans, and elastin) and DNA content increased to levels of native tissue and higher at 20 weeks. Conclusions—This study demonstrates in vitro generation of implantable complete living heart valves based on a biomimetic flow culture system. These autologous tissue-engineered valves functioned up to 5 months and resembled normal heart valves in microstructure, mechanical properties, and extracellular matrix formation.

[1]  F J Schoen,et al.  Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.

[2]  Robert Langer,et al.  Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation , 1999, The Lancet.

[3]  C K Breuer,et al.  Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. , 1996, Circulation.

[4]  C K Breuer,et al.  Tissue engineering lamb heart valve leaflets , 1996, Biotechnology and bioengineering.

[5]  I. Bergman,et al.  Two Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline. , 1963 .

[6]  F J Schoen,et al.  Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.

[7]  W. Strauss Preparation of Genomic DNA from Mammalian Tissue , 1993, Current protocols in immunology.

[8]  D J Wheatley,et al.  Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. , 1991, The New England journal of medicine.

[9]  J. Mayer Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. , 1995, Seminars in thoracic and cardiovascular surgery.

[10]  W G Henderson,et al.  A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1993, The New England journal of medicine.

[11]  W. Likoff,et al.  Valvular Heart Disease , 2018, The Perioperative Medicine Consult Handbook.

[12]  B. Carabello,et al.  Valvular heart disease. , 1997, The New England journal of medicine.

[13]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[14]  F J Schoen,et al.  Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. , 1997, The Journal of heart valve disease.

[15]  W. Strauss Preparation of Genomic DNA from Mammalian Tissue , 1998, Current protocols in molecular biology.